{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:47:35Z","timestamp":1762418855113,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.remnie.2022.11.003","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T12:23:05Z","timestamp":1668687785000},"page":"77-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["PET\/CT in nuclear endocrinology: Results of the survey diffused through different social networks of the SEMNIM in Spain"],"prefix":"10.1016","volume":"42","author":[{"given":"M.","family":"Negre Bus\u00f3","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Estorch Cabrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mitjavila Casanovas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remnie.2022.11.003_bib0005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1530\/EJE-19-0261","article-title":"Diagnostic performance of 18F-FDG-PET\/CT in DTC patients with thyroglobuline elevation and negative iodine scintigraphy: a meta-analysis","volume":"181","author":"Qichang","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.remnie.2022.11.003_bib0010","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.diii.2021.04.004","article-title":"PET\/CT in the management of differentiatied thyroid cancer. Diagnostic and interventional imaging","volume":"102","author":"Zampella","year":"2021","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.remnie.2022.11.003_bib0015","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1089\/thy.2020.0826","volume":"31","author":"Gulec","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.remnie.2022.11.003_bib0020","first-page":"186","article-title":"Utilidad de la 18F-FDG PET\/TC en el c\u00e1ncer de tiroides","volume":"35","author":"Muros","year":"2016","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"10.1016\/j.remnie.2022.11.003_bib0025","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1097\/RLU.0000000000002925","article-title":"Which is the optimal scan time of 18F-DOPA PET\/CT in patients with recurrent Medullary Thyroid Carcinoma? Results from a dynamic acquisition study","volume":"45","author":"Taralli","year":"2020","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.remnie.2022.11.003_bib0030","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s12020-021-02930-8","article-title":"Imaging medullary thyroid cancer patients with detectable serum markers: state of the art and future perspectives","volume":"75","author":"Klain","year":"2022","journal-title":"Endocrine"},{"key":"10.1016\/j.remnie.2022.11.003_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2022.104113","article-title":"Functional imaging in thyroid cancer patients with metastases and therapeutic implications","volume":"51","author":"Schlumberger","year":"2022","journal-title":"Presse Med"},{"key":"10.1016\/j.remnie.2022.11.003_bib0040","doi-asserted-by":"crossref","first-page":"756","DOI":"10.2967\/jnumed.116.185587","article-title":"The impact of somatostatine receptor-directed PET\/CT on the management of patients with neuroendocrine tumor: a systematic review and meta-analysis","volume":"58","author":"Barrio","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remnie.2022.11.003_bib0045","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11864-020-00770-8","article-title":"Anatomic and functional imaging of neuroendocrine tumors","volume":"21","author":"Morse","year":"2020","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.remnie.2022.11.003_bib0050","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2967\/jnumed.117.202275","article-title":"Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors","volume":"59","author":"Hope","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remnie.2022.11.003_bib0055","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejca.2021.01.008","article-title":"Consensus on molecular imaging and theranostics in neuroendocrine neoplasms","volume":"146","author":"Ambronsini","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.remnie.2022.11.003_bib0060","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12020-019-01895-z","article-title":"Novel PET tracers: added value for endocrine disorders","volume":"64","author":"Bergeret","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.remnie.2022.11.003_bib0065","doi-asserted-by":"crossref","first-page":"141","DOI":"10.23736\/S1824-4785.22.03450-1","article-title":"Molecular imaging of endocrine neoplasms with emphasis on 18F-DOPA PET: a practical approach for well-tailored imaging protocols","volume":"66","author":"Fargette","year":"2022","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remnie.2022.11.003_bib0070","first-page":"395","article-title":"Identification of occult adenomas in primary hyperparathyroidism with 18F fluorocholine PET\/CT","volume":"98","author":"Ballester","year":"2020","journal-title":"Cr Esp"},{"key":"10.1016\/j.remnie.2022.11.003_bib0075","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1007\/s00259-018-3980-9","article-title":"18 fluorocholine PET\/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT\/CT: a prospective dual-centre study in 100 patients","volume":"45","author":"Behesti","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.remnie.2022.11.003_bib0080","first-page":"273","article-title":"PET\/TC 4D 18F-colina en el hiperparatiroidismo: correlaci\u00f3n entre datos bioqu\u00edmicos y par\u00e1metros del estudio","volume":"39","author":"Boccalatte","year":"2020","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"10.1016\/j.remnie.2022.11.003_bib0085","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s00259-021-05334-y","article-title":"The EANM practice guidelines for parathyroid imaging","volume":"48","author":"Ovcaricek","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808922001094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808922001094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:44:41Z","timestamp":1762418681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253808922001094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2253808922001094"],"URL":"https:\/\/doi.org\/10.1016\/j.remnie.2022.11.003","relation":{},"ISSN":["2253-8089"],"issn-type":[{"type":"print","value":"2253-8089"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PET\/CT in nuclear endocrinology: Results of the survey diffused through different social networks of the SEMNIM in Spain","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remnie.2022.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2022.09.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}